GLEEVEC (imatinib) for Ph+ Chronic Myeloid Leukemia - Cancer Therapy Advisor

GLEEVEC (imatinib) for Ph+ Chronic Myeloid Leukemia

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for GLEEVEC (imatinib), indicated for Ph+ chronic myeloid leukemia.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 10: Use in Specific Populations
Slide 12: Clinical Pharmacology
Slide 17: Warnings and Precautions
Slide 22: Clinical Safety and Efficacy
Slide 30: Drug Storage and Supply
Slide 32: References

Next hm-slideshow in Slides